We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Expanding Possibilities for Compound Library Generation in Flow with Immobilized and Exchangeable Reagents

Video   Apr 29, 2016

 


About the Speaker
Noah Tu is a Senior Scientist with Discovery Chemistry and Technology at AbbVie Inc in North Chicago, Illinois. Noah has over 20 years of experience in the pharmaceutical industry. He joined Abbott Laboratories as a medicinal chemist in 1994 after graduating from University of Victoria in Canada. In 2000 Noah established the High Throughput Organic Synthesis group in Abbott Laboratories for compound library synthesis. In 2002 Noah joined S*BIO, a startup company in Singapore, and established the High Throughput Synthesis and Analytic group. Noah rejoined Abbott/AbbVie in 2006 and has pioneered in the setup of several novel integrated synthesis-purification systems for rapid compound library generation.
AbstractA custom-built modular flow reactor featuring immobilized reagents in exchangeable cartridges has been developed. The concept is based on a custom designed flow reactor with easy access to internal components for reagent cartridge exchange. Custom made reagent cartridges filled with different supported catalysts and reagents are used for various reaction conditions. The custom reactor has, as one component, the same footprint as the Accendo ConjureTM reactor and no hardware or software modification to the Conjure unit is required. This reactor opens the way to chemical transformations previously not readily achievable with Accendo Conjure flow chemistry system. In this presentation, we demonstrate the applicability of this system to tandem Click-Suzuki reactions.

 
 
 
Advertisement
 

Recommended Videos

TSE Explores Drug Discovery – Testing a Drug Compound: Clinical Trials

Video

In this episode we speak with Dr Stephen Wright, Consultant in Medicines Development from Limber Strategic, who talks to us about the clinical development of a drug, including how clinical trials are designed and the role of regulatory authorities in the process.

WATCH NOW

TSE Explores Drug Discovery – Identifying and Optimizing a Promising Drug

Video

In this episode we speak with Professor Paul Brennan from the University of Oxford about lead optimization, what to consider when designing a new drug, and much more.

WATCH NOW

TSE Explores Drug Discovery – How Are Drugs Developed?

Video

In this episode, we speak with Tomasz Kostrzewski, Director of Biology at CN Bio about how drugs are developed, including the challenges faced when designing and developing a drug, how drug discovery has evolved, and what trends we can expect to see in the future.

WATCH NOW

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE